Optimizing treatments in rare diseases: Will our evidence come from registry data?

被引：1

作者：

Almeida, Antonio M. ^{[1
]}

机构：

[1] Inst Portugues Oncol Lisboa, Serv Hematol, Lisbon, Portugal

来源：

LEUKEMIA RESEARCH | 2014年 / 38卷 / 04期

关键词：

CHRONIC MYELOMONOCYTIC LEUKEMIA; MYELODYSPLASTIC SYNDROMES; AZACITIDINE; 5-AZACYTIDINE; DIAGNOSIS;

D O I：

10.1016/j.leukres.2014.01.015

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：421 / 422

页数：2

共 50 条

[1] Diagnostic delay in rare diseases: data from the Spanish rare diseases patient registry
Benito-Lozano, Juan
Lopez-Villalba, Blanca
Arias-Merino, Greta
de la Paz, Manuel Posada
Alonso-Ferreira, Veronica
ORPHANET JOURNAL OF RARE DISEASES, 2022, 17 (01)
[2] Diagnostic delay in rare diseases: data from the Spanish rare diseases patient registry
Juan Benito-Lozano
Blanca López-Villalba
Greta Arias-Merino
Manuel Posada de la Paz
Verónica Alonso-Ferreira
Orphanet Journal of Rare Diseases, 17
[3] Where there is no evidence: A registry for rare benign diseases in Germany
Micke, O.
Seegenschmiedt, M. H.
Hesselmann, S.
Makoski, H. -B
STRAHLENTHERAPIE UND ONKOLOGIE, 2006, 182 : 68 - 69
[4] National platform for Rare Diseases Data Registry of Japan
Furusawa, Yoshihiko
Yamaguchi, Izumi
Yagishita, Naoko
Tanzawa, Kazumasa
Matsuda, Fumihiko
Yamano, Yoshihisa
Yamada, Ryo
Tabara, Yasuharu
Kamatani, Yoichiro
Kawaguchi, Syuji
Kosugi, Shinji
Higasa, Koichiro
Matsubara, Yoichi
Matsumoto, Naomichi
Aasano, Yoshihiro
Nishino, Ichizo
Nakamura, Harumasa
Takano, Atsushi
Iot, Motoi
Sakai, Shinya
LEARNING HEALTH SYSTEMS, 2019, 3 (03):
[5] Lessons from the Rare Diseases Registry and Analytics Platform framework for development of a national rare diseases registry for India
Pragya Chaube
Avani Lankapalli
Mohua Chakraborty Choudhury
Journal of Biosciences, 49
[6] Lessons from the Rare Diseases Registry and Analytics Platform framework for development of a national rare diseases registry for India
Chaube, Pragya
Lankapalli, Avani
Choudhury, Mohua Chakraborty
JOURNAL OF BIOSCIENCES, 2024, 49 (01)
[7] Real-world evidence for coverage determination of treatments for rare diseases
Victoria W. Dayer
Michael F. Drummond
Omar Dabbous
Mondher Toumi
Peter Neumann
Sean Tunis
Nelson Teich
Shadi Saleh
Ulf Persson
Johann-Matthias Graf von der Schulenburg
Daniel C. Malone
Tay Salimullah
Sean D. Sullivan
Orphanet Journal of Rare Diseases, 19
[8] Real-world evidence for coverage determination of treatments for rare diseases
Dayer, Victoria W.
Drummond, Michael F.
Dabbous, Omar
Toumi, Mondher
Neumann, Peter
Tunis, Sean
Teich, Nelson
Saleh, Shadi
Persson, Ulf
von der Schulenburg, Johann-Matthias Graf
Malone, Daniel C.
Salimullah, Tay
Sullivan, Sean D.
ORPHANET JOURNAL OF RARE DISEASES, 2024, 19 (01)
[9] A real-life analysis of patients with rheumatologic diseases on biological treatments: Data from TURKBIO Registry
Onen, Fatos
Can, Gercek
Capar, Sedat
Dalkilic, Ediz
Pehlivan, Yavuz
Senel, Soner
Akar, Servet
Koca, Suleyman Serdar
Tufan, Abdurrahman
Yazici, Ayten
Yilmaz, Sema
Inanc, Nevsun
Sari, Ismail
Birlik, Merih
Solmaz, Dilek
Cefle, Ayse
Ozturk, Mehmet Akif
Yolbas, Servet
Krogh, Niels Steen
Yilmaz, Neslihan
Erten, Sukran
Bes, Cemal
Gunduz, Ozgul Soysal
Goker, Berna
Haznedaroglu, Seminur
Yavuz, Sule
Cetin, Gozde Yildirim
Yildiz, Fatih
Direskeneli, Haner
Akkoc, Nurullah
EUROPEAN JOURNAL OF RHEUMATOLOGY, 2022, 9 (02) : 82 - 87
[10] Establishment of a registry of clinical data and bioresources for rare nervous system diseases
Kim, Dayoung
Kim, Sooyoung
Seok, Jin Myoung
Shin, Kyong Jin
Oh, Eungseok
Jeon, Mi Young
Park, Joungkyu
Chang, Hee Jin
Youn, Jinyoung
Oh, Jeeyoung
Sohn, Eunhee
Park, Jinse
Cho, Jin Whan
Kim, Byoung Joon
OSONG PUBLIC HEALTH AND RESEARCH PERSPECTIVES, 2024, 15 (02) : 174 - 181

← 1 2 3 4 5 →